JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and approve This is to intimate ....
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JB Chemicals & Pharmaceuticals has informed BSE that a Board of Directors meeting will be held on February 5, 2026. The Board will, among other things, consider and approve the declaration of an interim dividend for the financial year 2025-26, if any. The intimation has been made under Regulation 29 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. No specific dividend amount, record date, or other details have been disclosed at this stage.
Investors should watch for the Board's decision on February 5, as an interim dividend declaration could provide a near-term catalyst for the stock. However, the word 'if any' in the filing means a dividend is only being considered, not confirmed.